Some institutions use peripheral blood measurements of chromogranin A (CgA) and neuron specific enolase (NSE) as these have been shown to be elevated in some patients with high grade neuroendocrine carcinoma including SCLC and some LCNEC patients (74). The gene discussed is CGA; the disease is large cell neuroendocrine carcinoma.